Delex Pharma International, Inc. (DPII) is currently marketing seventeen (17) drugs in the Philippine market, in which nine (9) brands are competitively playing in their respective therapeutic classes. Majority of these products are either market leaders or second leading branded generics. These brands were built as Delex Pharma stays true to its commitment of providing quality and cost-effective medicines, as well as in supporting the Continuing Medical Education of our healthcare partners that helps enhance their clinical expertise to extend premium quality health care to critically-ill patients.

All DPII products requiring assay procedures passed the tests done by local centers that are recognized authorities for drug research and evaluation.